Last reviewed · How we verify
NCT03524391
Effect of Yoga Counselling on Quality of Life and Psychological Outcomes of Prostate Cancer Patients
NA trial testing Counselling based on yoga in Prostate Cancer in 92 participants. Completed in 25 February 2017.
5 January 2017
Quick facts
| Lead sponsor | NMP Medical Research Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 92 |
| Start date | 12 February 2016 |
| Primary completion | 5 January 2017 |
| Estimated completion | 25 February 2017 |
Drugs / interventions tested
- Counselling based on yoga
- Chemotherapy (chemotherapy) — full drug profile →
Conditions studied
- Prostate Cancer — all drugs for Prostate Cancer →
Sponsor
NMP Medical Research Institute
Who can join
Adults 40 to 60, male only, with Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cancer is second leading cause of death worldwide. The psychological issues are related to all stages of the disease affecting outcome of treatment and overall quality of life. The study evaluated the effectiveness of yoga counselling among prostate cancer patients on their quality of life and psychological outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03524391
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prostate Cancer
Currently open trials in the same condition.
- NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
- NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
- NCT07234981 — PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · Phase 2 · recruiting
- NCT07027124 — Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Ris · Phase 2 · recruiting
- NCT07426094 — PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate · Phase 2, PHASE3 · recruiting
Other NMP Medical Research Institute trials
Trials by the same sponsor.
- NCT04974853 — Cholesterol Lowering Effect of Cardio-Complement, an Ayurveda Formulation · NA · completed
- NCT04920773 — Community-based Post-exposure Prophylaxis for COVID-19 · NA · completed
- NCT04113512 — Yoga Nasal Irrigation in the Treatment of Chronic Tension Type Headache · NA · completed
- NCT04113460 — The Effectiveness Yoga@Work Among Office Workers With Chronic Nonspecific Neck Pain (CNNP) · NA · completed
- NCT04113473 — An Evaluation of Yoga Therapy for Cervical Spondylosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03524391 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NMP Medical Research Institute
- Last refreshed: 14 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03524391.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing